Pacific Biosciences Of California (PACB) Short-term Investments (2010 - 2026)
Pacific Biosciences Of California (PACB) posted quarterly Short-term Investments of $219.7 million for Q1 2026, down 22.81% year-over-year from $284.6 million in Q1 2025, and up 1098340.0% quarter-over-quarter from $20000.0 in Q4 2025.
Pacific Biosciences Of California (PACB) Short-term Investments (2010 - 2026) Analysis & Trends
Pacific Biosciences Of California's Short-term Investments history runs 17 years deep, the most recent figure standing at $219.7 million for Q1 2026.
- In Q1 2026, Short-term Investments fell 22.81% year-over-year to $219.7 million; the TTM figure through Mar 2026 stood at $219.7 million (down 22.81% YoY), while the FY2025 annual figure was $20000.0, down 97.1% from the prior year.
- Short-term Investments for Q1 2026 stood at $219.7 million, up from $20000.0 in the prior quarter.
- The five-year high for Short-term Investments was $534.2 million in Q1 2022, with the low at $20000.0 in Q4 2025.
- The 5-year median for Short-term Investments is $284.6 million (2025), against an average of $277.1 million.
- The sharpest annual moves came in 2023 and 2024: Short-term Investments slumped 99.93% in 2023, then jumped 136658.67% in 2024.
- Pacific Biosciences Of California's Short-term Investments stood at $447.2 million in 2022, then plunged by 99.93% to $300000.0 in 2023, then jumped by 130.0% to $690000.0 in 2024, then sank by 97.1% to $20000.0 in 2025, then soared by 1098340.0% to $219.7 million in 2026.
- Business Quant data shows PACB's Short-term Investments at $219.7 million in Q1 2026, $20000.0 in Q4 2025, and $242.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn |
| 10 | Pacific Biosciences Of California | 394.53 Mn | 157.66 Mn | 12.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 175.87 Mn |
| Mar 31, 2026 | 219.69 Mn |
| Dec 31, 2025 | 20,000.00 |
| Sep 30, 2025 | 242.19 Mn |
| Jun 30, 2025 | 259.93 Mn |
| Mar 31, 2025 | 284.60 Mn |
| Dec 31, 2024 | 690,000.00 |
| Sep 30, 2024 | 393.17 Mn |
| Jun 30, 2024 | 410.28 Mn |
| Mar 31, 2024 | 485.27 Mn |
| Dec 31, 2023 | 300,000.00 |
| Sep 30, 2023 | 382.14 Mn |
| Jun 30, 2023 | 300,000.00 |
| Mar 31, 2023 | 521.06 Mn |
| Dec 31, 2022 | 447.23 Mn |
| Sep 30, 2022 | 529.91 Mn |
| Jun 30, 2022 | 300,000.00 |
| Mar 31, 2022 | 534.20 Mn |
| Dec 31, 2021 | 500,000.00 |
| Jun 30, 2021 | 300,000.00 |